Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide

Blood

Volumn 99, Issue 4, 2002, Pages 1259-1266

  Smyth, Mark J ^a,b,c   Crowe, Nadine Y ^a,b,c   Pellicci, Daniel G ^a,b,c   Kyparissoudis, Konstantinos ^a,b,c   Kelly, Janice M ^a,b,c   Takeda, Kazuyoshi ^a,b,c   Yagita, Hideo ^a,b,c   Godfrey, Dale I ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FAS LIGAND; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; PERFORIN; RAG1 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; GENE TARGETING; LIVER METASTASIS; LUNG METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR REJECTION;

EID: 0037082487     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1259     Document Type: Article

References (68)

1. Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor T-cell hybridoma
2. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family
3. Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice
4. Mouse CD1-specific NK1 T cells: Development, specificity, and function
5. NK1.1 + T cell receptor-alpha/beta+ cells: New clues to their origin, specificity, and function
6. Antigen-presenting function of mouse CD1: One molecule with two different kinds of antigenic ligands
7. CD1-mediated immune responses to glycolipids
8. Requirement for Vαd4 NKT cells in IL-12-mediated rejection of tumors
9. CD4pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3
10. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
11. Selective ability of mouse CD1 to present glycolipids: Alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes
12. Liver NK1.1 + CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
13. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
14. Differential tumor surveillance by natural killer (NK) and NKT cells
15. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells
16. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
17. The antitumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
18. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
19. alpha/beta-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of inteleukin (IL)-4 and/or IL-10
20. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
21. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance
22. CD4(+) Valpha 14 natural killer T cells are essential for acceptance of rat islet xenografts in mice
23. NKT cells: Facts, functions and fallacies
24. NKT cells and tumor immunity: A double-edged sword
25. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice
26. KRN7000, a novel immunomodulator, and its antitumor activities
27. Structural requirements for galactosylceramide recognition by CD1 - restricted NK T cells
28. Critical role of NK1 + T cells in IL-12-induced immune responses in vivo
29. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000
30. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
31. The natural killer T (NKT) cell ligand alpha-galactosylcer-amide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
32. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
33. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
34. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide
35. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers
36. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes
37. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
38. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide
39. Cutting edge: Activation of NK T cells by CD1d and alphagalactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
40. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
41. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells
42. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1 d-expressing dendritic cells to NKT cells induces the differentiation of antigen -specific cytotoxic T lymphocytes
43. α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells
44. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
45. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
46. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
47. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses
48. Defective NK cell activity and Th1 response in IL-18-deficient mice
49. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
50. NKT cells are phenotypically and functionally diverse
51. Perforin is a major contributor to NK cell control of tumor metastasis
52. NK cells and NKT cells collaborate in host protection from methytcholanthrene-induced fibrosarcoma
53. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: Evidence for a T cell-dependent, interferon gamma-independent mechanism
54. Involvement of decidual Valpha 14 NKT cells in abortion
55. Fas-mediated cytotoxicity by freshly isolated natural killer cells
56. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver
57. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement
58. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells
59. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
60. Hypoxiamediated apoptosis from angiogenesis inhibition underlies tumor control by recombinant interleukin 12
61. Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
62. Mig and IP-10: CXC chemokines that target lymphocytes
63. TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells
64. NKT cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
65. Cutting edge: Selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection
66. In vivo identification of glycolipid antigenspecific T cells using fluorescent CD1d tetramers
67. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen
68. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways